JAEB CENTER FOR HEALTH RESEARCH, INC.

Tampa, FL

OncologymRNAPhase II

Compare Sign in to watch

What changed

Study registered, no phase assigned: Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear

2mo agoTrial registeredMay 1, 2026Source filing (opens the source filing in a new tab)

Momentum

80no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
Sep 1, 2025
Lung Cancer (Diagnosis) · NOT_YET_RECRUITING · sponsor: Shanghai Chest Hospital · Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
ClinicalTrials.gov · NCT07135297 (opens the source filing in a new tab)
Grant
U54 · $209k · non-dilutive
Feb 1, 2025
STANFORD UNIVERSITY · PI DE MELO-MARTIN, INMACULADA · NIA · award ends Jan 31, 2030 · VAST Center: Viromes Across Space(s) and Time
NIH RePORTER · NIH RePORTER 10990426 (opens the source filing in a new tab)
Grant
P50 · $199k · non-dilutive
Apr 5, 2023
UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DAVIS-MARTIN, RACHEL ELIZABETH · NIMH · award ends Mar 31, 2028 · Exploratory Research Project - CAT
NIH RePORTER · NIH RePORTER 11056013 (opens the source filing in a new tab)
Grant
P20 · $326k · non-dilutive
Apr 1, 2023
MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PENROD-MARTIN, RACHEL · NIGMS · award ends Feb 29, 2028 · Mouse Behavior Phenotyping Core
NIH RePORTER · NIH RePORTER 11049132 (opens the source filing in a new tab)
Grant
R01 · $678k · non-dilutive
Feb 1, 2023
UNIVERSITY OF VIRGINIA · PI TEAGUE, WILLIAM GERALD · NIAID · award ends Jan 31, 2028 · Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
NIH RePORTER · NIH RePORTER 11010411 (opens the source filing in a new tab)
Grant
K01 · $136k · non-dilutive
Jul 25, 2022
JOHNS HOPKINS UNIVERSITY · PI SUN, JING · NIAID · award ends Jun 30, 2027 · Collaboration on HIV and AgingResearch through the Study of Mitochondria
NIH RePORTER · NIH RePORTER 11143842 (opens the source filing in a new tab)
Trial
NA registered
Mar 22, 2022
Headache · RECRUITING · sponsor: University of Alcala · Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear
ClinicalTrials.gov · NCT05662722 (opens the source filing in a new tab)
Trial
PHASE2 registered
Mar 1, 2022
Nasopharyngeal Carcinoma · RECRUITING · sponsor: Xinqiao Hospital of Chongqing · Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
ClinicalTrials.gov · NCT05147844 (opens the source filing in a new tab)
Grant
R01 · $615k · non-dilutive
Aug 15, 2020
UNIVERSITY OF VIRGINIA · PI SUN, JIE · NIA · award ends Apr 30, 2030 · Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection
NIH RePORTER · NIH RePORTER 11130577 (opens the source filing in a new tab)
Grant
R01 · $643k · non-dilutive
Feb 14, 2020
UNIVERSITY OF VIRGINIA · PI SUN, JIE · NIAID · award ends May 31, 2030 · Host cellular network governing the development of post SARS-CoV-2 tissue sequelae
NIH RePORTER · NIH RePORTER 11044253 (opens the source filing in a new tab)
Grant
UG1 · $11M · non-dilutive
Sep 30, 2002
JAEB CENTER FOR HEALTH RESEARCH, INC. · PI GLASSMAN, ADAM R · NEI · award ends Dec 31, 2028 · DRCR Retina Network
NIH RePORTER · NIH RePORTER 11004950 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 78%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75principal investigator DE MELO-MARTIN, INMACULADA is named on this company's filings
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear
2mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
11mo agoTrial registeredSource (opens the source filing in a new tab)
Phase II trial registered: Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Jul 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Jul 2025Trial recruitingSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH P20 · $0.3M · Mouse Behavior Phenotyping Core
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH K01 · $0.1M · Collaboration on HIV and AgingResearch through the Study of Mitochondria
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Host cellular network governing the development of post SARS-CoV-2 tissue sequelae
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH P50 · $0.2M · Exploratory Research Project - CAT
Apr 2025Grant renewalSource (opens the source filing in a new tab)
NIH UG1 · $11M · DRCR Retina Network
Feb 2025Grant renewalSource (opens the source filing in a new tab)
NIH U54 · $0.2M · VAST Center: Viromes Across Space(s) and Time
Jan 2025New grantSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

NA registered

U54 · $209k · non-dilutive

P50 · $199k · non-dilutive

P20 · $326k · non-dilutive

R01 · $678k · non-dilutive

K01 · $136k · non-dilutive

NA registered

PHASE2 registered

R01 · $615k · non-dilutive

R01 · $643k · non-dilutive

UG1 · $11M · non-dilutive